CoChat

FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma

Open access
Chung, Catherine T-S, Santos, Gilda Da Cunha, Hwang, David M, Ludkovski, Olga, Pintilie, Melania, Squire, Jeremy A, Tsao, Ming-Sound · 2010 · Journal of Clinical Pathology
Cited by 95

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Aims: To develop a fluorescence in-situ hybridisation (FISH) assay for detecting p16/CDKN2A deletion on paraffin tissue sections for use as an ancillary test to distinguish reactive from malignant mesothelial proliferations. Method: Dual-colour FISH for p16/CDKN2A and chromosome 9 (CEP-9) was performed on 11 benign mesothelial proliferations and 54 malignant pleural mesothelioma (MPM) cases to establish cut-off values for p16/CDKN2A deletion. A third MYC probe was used to verify cases showing homozygous deletion. Eight equivocal biopsies were used for assay testing. Results: Cut-off values for p16/CDKN2A deletion were calculated based on FISH signalling patterns obtained from the benign controls (mean percent nuclei plus three standard deviations). Hemizygous deletion was defined as >44% of nuclei showing the hemizygous (one p16/CDKN2A , two CEP-9 signals) or >15% of nuclei showing the monosomy (one p16/CDKN2A , one CEP-9 signal) deletion patterns. None of the benign cases showed a homozygous deletion pattern (no p16/CDKN2A , at least one CEP-9 signal). In the malignant cases, the percentage of nuclei showing homozygous deletion ranged from 1% to 87%. Therefore, the cut-off value for homozygous deletion was defined as >10%. P16/CDKN2A deletion was detected in 61% (33/54) of MPM cases. Among the equivocal biopsies, four showed homozygous and one showed hemizygous p16/CDKN2A deletion. Age over 60 years, asbestos exposure and p16/CDKN2A deletion were associated with a worse prognosis. Conclusion: Distinction between benign and malignant mesothelial proliferations can be diagnostically challenging. FISH for p16/CDKN2A deletion is a useful test for confirming the diagnosis of MPM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jcp.2010.076794

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 95

Metadata

Authors
Chung, C. T.-S., Santos, G. D. C., Hwang, D. M., Ludkovski, O., Pintilie, M., Squire, J. A., & Tsao, M.-S.
Venue
Journal of Clinical Pathology
Publisher
BMJ
Published
2010-06-30
Volume
63
Issue
7
Pages
630-634
ISSN
  • 0021-9746 (ISSN-L)
  • 1472-4146
OpenAlex
W2165354014
Cited by
95
References
1
FWCI
3.94
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma. https://app.cochat.ai/papers/10.1136/jcp.2010.076794
The paper
Chung, C. T.-S., Santos, G. D. C., Hwang, D. M., Ludkovski, O., Pintilie, M., Squire, J. A., & Tsao, M.-S. (2010). FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma. Journal of Clinical Pathology. https://doi.org/10.1136/jcp.2010.076794

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.